Program
ferric carboxymaltose
Also written as “Ferric Carboxymaltose (FCM)”, “Ferric carboxymaltose” and “Injectafer”.
Its studies are mostly in Anemia, Iron-Deficiency · Anemia · Iron Deficiencies · Restless Legs Syndrome · Heart Failure, led by 4 companies.
Drug pageFerric carboxymaltose: every studyAll 158 studies of it, academic ones too, with its approvals, label and forms.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Daiichi Sankyo | 280 open or running | phase 4since Sep 23, 2013 | Apr 20, 2006 | none ahead |
| CSLits history only | 140 open or running | phase 4since Mar 29, 2010 | Aug 24, 2007 | none ahead |
| Sichuan Huiyu Pharmaceuticalits history only | 31 open or running | phase 1since Sep 27, 2023 | Sep 27, 2023 | none ahead |
| Novartisits history only | 10 open or running | phase 1since Dec 5, 2017 | Dec 5, 2017 | none ahead |
Also a collaborator on its studies: Suzhou Guochen Biotechnology, Boji Medical Technology, ClinStar, Cytel, Tigermed Consulting, Pierrel Research Europe, ICON Clinical Research, Parexel and SGS.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Daiichi Sankyo only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 14 studies since Apr 20, 2006.
- Oct 4, 2010Phase 2 study in Anemia, Iron-DeficiencyNCT01307007 · 69 enrolled
- Nov 10, 2010Phase 2 study in Anemia, Iron-DeficiencyNCT01290315 · 49 enrolled · United States
- Feb 23, 2011Phase 2 study in Restless Legs SyndromeNCT01382901 · 45 enrolled
- Sep 23, 2013Phase 4 study in Anemia, Iron-DeficiencyNCT01950247 · 1,025 enrolled
- Mar 12, 2014Phase 4 study in Iron Deficiency Anemia Secondary to IBD or Gastric BypassNCT02086968 · 198 enrolled
- Mar 18, 2015Phase 3 study in Restless Legs SyndromeNCT02397057 · 209 enrolled · United States
- Mar 27, 2015Phase 2 study in Anemia, Iron-DeficiencyNCT02410213 · 35 enrolled · Poland, Russian Federation
- Apr 1, 2015Phase 2 study in Iron DeficienciesNCT02409459 · 81 enrolled · United States
- May 21, 2015Phase 3 study in NeoplasmsNCT02453334 · 244 enrolled · United States
- Jun 30, 2016Phase 2 study in Restless Legs SyndromeNCT02826681 · 70 enrolled · United States
- Jan 25, 2017Phase 3 study in Heart FailureNCT03037931 · 3,065 enrolled · United States, Australia, Bulgaria and more
- Apr 17, 2018Phase 3 study in Anemia, Iron-DeficiencyNCT03523117 · 79 enrolled · United States
- Feb 12, 2020Phase 3 study in Anemia, Iron-DeficiencyNCT04269707 · 7 enrolled · United States
- Nov 2, 2020Phase 2 study in Anemia, Iron-DeficiencyNCT04968379 · United States
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 28 Daiichi Sankyo leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT04968379Anemia, Iron-Deficiency · United States | 2 | Withdrawn | Oct 8, 2024 | 0 |
| NCT04269707Anemia, Iron-Deficiency · United States | 3 | Completed | Dec 30, 2020 | 7 |
| NCT03523117Anemia, Iron-Deficiency · United States | 3 | Completed | Dec 22, 2020 | 79 |
| NCT03037931Heart Failure · United States, Australia, Bulgaria and more | 3 | Completed | Feb 2, 2023 | 3,065 |
| NCT02826681Restless Legs Syndrome · United States | 2 | Terminated | Sep 4, 2021 | 70 |
| NCT02453334Neoplasms · United States | 3 | Completed | Jan 2018 | 244 |
| NCT02409459Iron Deficiencies · United States | 2 | Completed | Oct 2015 | 81 |
| NCT02410213Anemia, Iron-Deficiency · Poland, Russian Federation | 2 | Completed | Jan 22, 2017 | 35 |
| NCT02397057Restless Legs Syndrome · United States | 3 | Completed | Jan 2018 | 209 |
| NCT02086968Iron Deficiency Anemia Secondary to IBD or Gastric Bypass | 4 | Completed | Jul 16, 2016 | 198 |
| NCT01950247Anemia, Iron-Deficiency | 4 | Completed | May 20, 2015 | 1,025 |
| NCT01382901Restless Legs Syndrome | 2 | Completed | Jul 2007 | 45 |
| NCT01290315Anemia, Iron-Deficiency · United States | 2 | Completed | Mar 2013 | 49 |
| NCT01307007Anemia, Iron-Deficiency | 2 | Completed | May 2011 | 69 |
| NCT00982007Anemia, Iron-Deficiency · United States | 3 | Completed | Mar 2011 | 997 |
| NCT00981045Anemia, Iron-Deficiency · United States | 3 | Completed | Jul 2011 | 2,561 |
| NCT00740246Anemia · United States | 3 | Completed | Feb 2006 | 594 |
| NCT00704353Anemia · United States | 3 | Completed | Jul 2009 | 735 |
| NCT00704028Anemia · United States | 3 | Completed | Jan 2010 | 161 |
| NCT00703937Anemia · United States | 3 | Completed | Jul 2009 | 708 |
| NCT00685815Restless Legs Syndrome · United States | 2 | Completed | Dec 2010 | 12 |
| NCT00548860Anemia · United States | 3 | Completed | Mar 2009 | 2,018 |
| NCT00548691Anemia · United States | 3 | Completed | Jan 2009 | 513 |
| NCT00396292Anemia · United States | 3 | Completed | Nov 2005 | 361 |
| NCT00395993Anemia · United States | 3 | Completed | Apr 2006 | 456 |
| NCT00354484Anemia · United States | 3 | Completed | Dec 2006 | 291 |
| NCT00317239Anemia · United States | 3 | Completed | Feb 2007 | 255 |
| NCT00317226Anemia · United States | 3 | Completed | Mar 2007 | 145 |
How it is read
Names in the registry
- “Ferric Carboxymaltose (FCM)”, 13 entries
- “Ferric carboxymaltose”, 8 entries
- “Injectafer”, 5 entries
- “Ferric Carboxymaltose”, 5 entries
- “Ferric Carboxymaltose Injection”, 3 entries
Conditions, from the studies’ own filings
- Anemia, Iron-Deficiency, 17 studies
- Anemia, 12 studies
- Iron Deficiencies, 7 studies
- Restless Legs Syndrome, 4 studies
- Heart Failure, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.